More than a million Singaporeans and permanent residents aged 40 and above have signed up for Healthier SG, but not all have ...

Report Ocean has unveiled an extensive market research report on the Antidepressant Drugs Market industry, spanning over 150+ countries and drawing insights from more than 100,000 published and ...

Men's Health Month is the perfect time to take a step back, reflect on your health, and make positive changes that can lead ...

PTSD - highest in any Indian region Kashmir, often described as a paradise on earth, has been plagued by conflict for decade ...

In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major depressive disorder (MDD ... and higher levels of treatment resistance.

I’ve just finished watching the second season of Nine Perfect Strangers, and as a self-confessed wellness enthusiast, the ...

Based on a national survey of 36,309 adults, twenty-six percent of women reported experiencing major depressive disorder at some ... Finding the right treatment can be challenging—around 30% ...

(“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD ...

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder. The San Diego ...

Please provide your email address to receive an email when new articles are posted on . Spravato is the first monotherapy for adults with major depressive disorder who had an inadequate response ...

Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.

a 10-question diagnostic questionnaire used by mental-health professionals to measure the severity of depressive symptoms. The treatment also failed to meet a secondary endpoint of change from ...